InChI=1S/C22H32O4/c1-2-3-10-15-20(23)16-11-7-5-4-6-8-12-17-21(24)18-13-9-14-19-22(25)26/h3,5-13,16-17,20-21,23-24H,2,4,14-15,18-19H2,1H3,(H,25,26)/b7-5-,8-6-,10-3-,13-9-,16-11+,17-12+/t20-,21+/m0/s1 |
CFOFZYMMJZILHE-XGTWDWJNSA-N |
CC\C=C/C[C@H](O)\C=C\C=C/C\C=C/C=C/[C@@H](O)C\C=C/CCC(O)=O |
|
Mus musculus
(NCBI:txid10090)
|
See:
PubMed
|
Trypanosoma cruzi
(NCBI:txid5693)
|
See:
PubMed
|
Oncorhynchus mykiss
(NCBI:txid8022)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
marine xenobiotic metabolite
Any metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
animal metabolite
Any eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4Z,7S,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosa-4,8,10,13,15,19-hexaenoic acid
|
(4Z,7S,8E,10Z,13Z,15E,17S,19Z)-7,17-dihydroxydocosahexaenoic acid
|
ChEBI
|
7(S),17(S)-diHDHA
|
ChEBI
|
7(S),17(S)-resolvin D5
|
ChEBI
|
7S,17S-diHDHA
|
ChEBI
|
7S,17S-dihydroxy-4Z,8E,10Z,13Z,15E,19Z-docosahexaenoic acid
|
ChEBI
|
resolvin-D5
|
ChEBI
|
RvD5
|
ChEBI
|
578008-43-2
|
CAS Registry Number
|
ChEBI
|
16303609
|
PubMed citation
|
Europe PMC
|
22538616
|
PubMed citation
|
Europe PMC
|
22841830
|
PubMed citation
|
Europe PMC
|
27320930
|
PubMed citation
|
Europe PMC
|
27632672
|
PubMed citation
|
Europe PMC
|
28098462
|
PubMed citation
|
Europe PMC
|
28694292
|
PubMed citation
|
Europe PMC
|
29358332
|
PubMed citation
|
Europe PMC
|
31333464
|
PubMed citation
|
Europe PMC
|
31693828
|
PubMed citation
|
Europe PMC
|
32404334
|
PubMed citation
|
Europe PMC
|
33047359
|
PubMed citation
|
Europe PMC
|
PMC7257705
|
PubMed Central citation
|
Europe PMC
|
|